+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Antiviral Drugs Market Report 2022-2032 - Product Thumbnail Image

Antiviral Drugs Market Report 2022-2032

  • Report
  • November 2022
  • 285 Pages
  • Global
From
Leukemia Therapeutics Global Market Report 2024 - Product Thumbnail Image

Leukemia Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 240 Pages
  • Global
From
From
From
From
From
From
From
Waldenstrom Macroglobulinemia - Pipeline Insight, 2024 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
5' Nucleotidase - Pipeline Review, H1 2020 - Product Thumbnail Image

5' Nucleotidase - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 109 Pages
  • Global
From
Chronic lymphocytic leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic lymphocytic leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Loading Indicator